These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31706704)

  • 1. Biological regulation of diacylglycerol kinases in normal and neoplastic tissues: New opportunities for cancer immunotherapy.
    Arranz-Nicolás J; Mérida I
    Adv Biol Regul; 2020 Jan; 75():100663. PubMed ID: 31706704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacylglycerol kinases in cancer.
    Mérida I; Torres-Ayuso P; Ávila-Flores A; Arranz-Nicolás J; Andrada E; Tello-Lafoz M; Liébana R; Arcos R
    Adv Biol Regul; 2017 Jan; 63():22-31. PubMed ID: 27697466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redundant and specialized roles for diacylglycerol kinases α and ζ in the control of T cell functions.
    Mérida I; Andrada E; Gharbi SI; Ávila-Flores A
    Sci Signal; 2015 Apr; 8(374):re6. PubMed ID: 25921290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diacylglycerol kinase α inactivation is an integral component of the costimulatory pathway that amplifies TCR signals.
    Arranz-Nicolás J; Ogando J; Soutar D; Arcos-Pérez R; Meraviglia-Crivelli D; Mañes S; Mérida I; Ávila-Flores A
    Cancer Immunol Immunother; 2018 Jun; 67(6):965-980. PubMed ID: 29572701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.
    Riese MJ; Wang LC; Moon EK; Joshi RP; Ranganathan A; June CH; Koretzky GA; Albelda SM
    Cancer Res; 2013 Jun; 73(12):3566-77. PubMed ID: 23576561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.
    Arranz-Nicolás J; Martin-Salgado M; Adán-Barrientos I; Liébana R; Del Carmen Moreno-Ortíz M; Leitner J; Steinberger P; Ávila-Flores A; Merida I
    Cancer Immunol Immunother; 2021 Nov; 70(11):3277-3289. PubMed ID: 33837851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diacylglycerol Kinase Malfunction in Human Disease and the Search for Specific Inhibitors.
    Merida I; Arranz-Nicolás J; Torres-Ayuso P; Ávila-Flores A
    Handb Exp Pharmacol; 2020; 259():133-162. PubMed ID: 31227890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of diacylglycerol kinases in immune-mediated diseases.
    Baldanzi G; Ragnoli B; Malerba M
    Clin Sci (Lond); 2020 Jul; 134(13):1637-1658. PubMed ID: 32608491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DgMab-6: Antihuman DGKγ Monoclonal Antibody for Immunocytochemistry.
    Nakano T; Ogasawara S; Tanaka T; Hozumi Y; Yamaki A; Sakane F; Shirai Y; Nakamura T; Yanaka M; Yamada S; Kaneko MK; Kato Y; Goto K
    Monoclon Antib Immunodiagn Immunother; 2018 Nov; 37(5):229-232. PubMed ID: 30362931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
    Purow B
    Clin Cancer Res; 2015 Nov; 21(22):5008-12. PubMed ID: 26420856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Mediated Knockout of DGK Improves Antitumor Activities of Human T Cells.
    Jung IY; Kim YY; Yu HS; Lee M; Kim S; Lee J
    Cancer Res; 2018 Aug; 78(16):4692-4703. PubMed ID: 29967261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β.
    Arumugam V; Bluemn T; Wesley E; Schmidt AM; Kambayashi T; Malarkannan S; Riese MJ
    J Leukoc Biol; 2015 Nov; 98(5):703-12. PubMed ID: 26153417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diacylglycerol kinase control of protein kinase C.
    Mérida I; Arranz-Nicolás J; Rodríguez-Rodríguez C; Ávila-Flores A
    Biochem J; 2019 Apr; 476(8):1205-1219. PubMed ID: 31000624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diacylglycerol kinases: A look into the future of immunotherapy.
    Martin-Salgado M; Ochoa-Echeverría A; Mérida I
    Adv Biol Regul; 2024 Jan; 91():100999. PubMed ID: 37949728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy.
    Noessner E
    Front Cell Dev Biol; 2017; 5():16. PubMed ID: 28316970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant contribution of DGKζ over DGKα in the control of PKC/PDK-1-regulated functions in T cells.
    Ávila-Flores A; Arranz-Nicolás J; Andrada E; Soutar D; Mérida I
    Immunol Cell Biol; 2017 Jul; 95(6):549-563. PubMed ID: 28163304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy.
    Olenchock BA; Guo R; Carpenter JH; Jordan M; Topham MK; Koretzky GA; Zhong XP
    Nat Immunol; 2006 Nov; 7(11):1174-81. PubMed ID: 17028587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diacylglycerol kinases put the brakes on immune function.
    Wattenberg BW; Raben DM
    Sci STKE; 2007 Aug; 2007(398):pe43. PubMed ID: 17684297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus.
    Tabellini G; Bortul R; Santi S; Riccio M; Baldini G; Cappellini A; Billi AM; Berezney R; Ruggeri A; Cocco L; Martelli AM
    Exp Cell Res; 2003 Jul; 287(1):143-54. PubMed ID: 12799190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
    Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
    J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.